Nanomedicine applications in women’s health: state of the art

References

• KoopmansRJAggeliANanobiotechnology – quo vadis?Curr Opin Microbiol201013332733420149720
   PubMed Web of Science ®Google Scholar
• EmerichDFNanomedicine – prospective therapeutic and diagnostic applicationsExpert Opin Biol Ther2005511515709905
   PubMed Web of Science ®Google Scholar
• AlbaneseATangPSChanWCWThe effect of nanoparticle size, shape, and surface chemistry on biological systemsYarmushMLPalo Alto, CAAnnual Review of Biomedical Engineering142012116
   Google Scholar
• High Quality Women’s Health Care: a proposal for change [webpage on the Internet]LondonRoyal College of Obstetrics and Gynaecologists2011 Available from: http://www.rcog.org.uk/high-quality-womens-health-careAccessed February 20, 2017
   Google Scholar
• Tomorrow’s Specialist RCOG [webpage on the Internet]LondonRoyal College of Obstetrics and Gynaecologists2011 Available from: https://www.rcog.org.uk/en/guidelines-research-services/guidelines/tomorrows-specialistAccessed February 20, 2017
   Google Scholar
• BitzerJHorneAWA new age has come: the redefinition of women’s health careJ Fam Plan Reprod H20123826869
   PubMedGoogle Scholar
• StephensonJALife-course approach to women’s health: implications for health care and implementation in the United Kingdom (UK) [webpage on the Internet]LondonWHO/Europe2015 Available from: http://www.euro.who.int/__data/assets/pdf_file/0016/292201/Life-Course-Approach-Womens-Health-UK.pdf?ua=1Accessed February 21, 2017
   Google Scholar
• JainRKStylianopoulosTDelivering nanomedicine to solid tumorsNat Rev Clin Oncol201071165366420838415
   PubMed Web of Science ®Google Scholar
• SargentJCardiovascular disease: new nanomedicines for treating atherosclerotic plaquesNat Rev Endocrinol201511525625752278
   PubMed Web of Science ®Google Scholar
• LamprechtANanomedicines in gastroenterology and hepatologyNat Rev Gastroenterol Hepatol201512419520425752711
   PubMed Web of Science ®Google Scholar
• BarrancoCAutoimmunity: nanomedicine, meet autoimmune diseaseNat Rev Rheumatol2016124193
   PubMedGoogle Scholar
• BellIRSchwartzGEBoyerNNKoithanMBrooksAJAdvances in integrative nanomedicine for improving infectious disease treatment in public healthEur J Integr Med20135212614023795222
   PubMed Web of Science ®Google Scholar
• SrikanthMKesslerJANanotechnology-novel therapeutics for CNS disordersNat Rev Neurol20128630731822526003
   PubMed Web of Science ®Google Scholar
• DeningTJRaoSThomasNPrestidgeCAOral nanomedicine approaches for the treatment of psychiatric illnessesJ Control Release201622313715626739547
   PubMed Web of Science ®Google Scholar
• MazaheriMEslahiNOrdikhaniFTamjidESimchiANanomedicine applications in orthopedic medicine: state of the artInt J Nanomedicine2015106039605326451110
   PubMed Web of Science ®Google Scholar
• BarkalinaNCharalambousCJonesCCowardKNanotechnology in reproductive medicine: emerging applications of nanomaterialsNanomedicine201410592193824444494
   PubMed Web of Science ®Google Scholar
• UskokovicVEntering the era of nanoscience: time to be so smallJ Biomed Nanotechnol2013991441147023980495
   PubMed Web of Science ®Google Scholar
• MahajanSDAalinkeelRLawWCAnti-HIV-1 nanotherapeutics: promises and challenges for the futureInt J Nanomedicine201275301531423055735
   PubMed Web of Science ®Google Scholar
• McManusSBPJenkinsRBrughaTMental health and wellbeing in England: Adult Psychiatric Morbidity Survey 2014 Leeds [webpage on the Internet] Available from: http://content.digital.nhs.uk/catalogue/PUB21748/apms-2014-full-rpt.pdfAccessed February 21, 2017
   Google Scholar
• VermeidenMvan den BroekWWMulderPGHBirkenhagerTKInfluence of gender and menopausal status on antidepressant treatment response in depressed inpatientsJ Psychopharmacol201024449750219423613
   PubMed Web of Science ®Google Scholar
• GoelNPlylerKSDanielsDBaleTLAndrogenic influence on serotonergic activation of the HPA stress axisEndocrinology201115252001201021385938
   PubMed Web of Science ®Google Scholar
• El-HageWLemanSCamusVBelzungCMechanisms of antidepressant resistanceFront Pharmacol2013414624319431
   PubMed Web of Science ®Google Scholar
• AlyautdinRKhalinINafeezaMIHaronMHKuznetsovDNanoscale drug delivery systems and the blood–brain barrierInt J Nanomedicine2014979581124550672
   PubMed Web of Science ®Google Scholar
• LöscherWPotschkaHBlood-brain barrier active efflux transporters: ATP-binding cassette gene familyNeuroRx200521869815717060
   PubMedGoogle Scholar
• UhrMStecklerTYassouridisAHolsboerFPenetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to mdr1a P-glycoprotein gene disruptionNeuropsychopharmacol2000224380387
   PubMed Web of Science ®Google Scholar
• UhrMGrauerMTHolsboerFDifferential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-glycoprotein gene disruptionBiol Psychiatry200354884084614550684
   PubMed Web of Science ®Google Scholar
• UhrMGrauerMTabcb1ab P-glycoprotein is involved in the uptake of citalopram and trimipramine into the brain of miceJ Psychiatr Res200337317918512650738
   PubMed Web of Science ®Google Scholar
• KarlssonLCarlssonBHiemkeCAltered brain concentrations of citalopram and escitalopram in P-glycoprotein deficient mice after acute and chronic treatmentEur Neuropsychopharm2013231116361644
   PubMed Web of Science ®Google Scholar
• KatoMFukudaTSerrettiAABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorderProg Neuropsychopharmacol Biol Psychiatry200832239840417913323
   PubMed Web of Science ®Google Scholar
• UhrMTontschANamendorfCPolymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depressionNeuron200857220320918215618
   PubMed Web of Science ®Google Scholar
• SarginsonJELazzeroniLCRyanHSErshoffBDSchatzbergAFMurphyGMABCB1 (MDR1) polymorphisms and antidepressant response in geriatric depressionPharmacogenet Genomics201020846747520555295
   PubMed Web of Science ®Google Scholar
• LinKMChiuYFTsaiIJABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatmentPharmacogenet Genomics201121416317020859246
   PubMed Web of Science ®Google Scholar
• SinghABBousmanCANgCHByronKBerkMABCB1 polymorphism predicts escitalopram dose needed for remission in major depressionTransl Psychiatry20122e19823188198
   PubMed Web of Science ®Google Scholar
• RobertsRLJoycePRMulderRTBeggEJKennedyMAA common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depressionPharmacogenomics J20022319119612082591
   PubMedGoogle Scholar
• JensenBPRobertsRLVyasRBonkeGJardineDLBeggEJInfluence of ABCB1 (P-glycoprotein) haplotypes on nortriptyline pharmacokinetics and nortriptyline-induced postural hypotension in healthy volunteersBr J Clin Pharmacol201273461962821999196
   PubMed Web of Science ®Google Scholar
• de KlerkOLNolteIMBetPMABCB1 gene variants influence tolerance to selective serotonin reuptake inhibitors in a large sample of Dutch cases with major depressive disorderPharmacogenomics J201313434935322641028
   PubMed Web of Science ®Google Scholar
• LaikaBLeuchtSSteimerWABCB1 (P-glycoprotein/MDR1) gene G2677T/a sequence variation (polymorphism): lack of association with side effects and therapeutic response in depressed inpatients treated with amitriptylineClin Chem200652589389516638956
   PubMed Web of Science ®Google Scholar
• Mihaljevic PelesABozinaNSagudMRojnic KuzmanMLovricMMDR1 gene polymorphism: therapeutic response to paroxetine among patients with major depressionProg Neuropsychopharmacol Biol Psychiatry20083261439144418550244
   PubMed Web of Science ®Google Scholar
• MenuPGressierFVerstuyftCHardyPBecquemontLCorrubleEAntidepressants and ABCB1 gene C3435T functional polymorphism: a naturalistic studyNeuropsychobiology201062319319720664232
   PubMed Web of Science ®Google Scholar
• AshokBArlethLHjelmRPRubinsteinIOnyukselHIn vitro characterization of PEGylated phospholipid micelles for improved drug solubilization: effects of PEG chain length and PC incorporationJ Pharm Sci200493102476248715349957
   PubMed Web of Science ®Google Scholar
• Leyva-GómezGGonzález-TrujanoMELópez-RuizENanoparticle formulation improves the anticonvulsant effect of clonazepam on the pentylenetetrazole-induced seizures: behavior and electroencephalogramJ Pharm Sci201410382509251924916334
   PubMed Web of Science ®Google Scholar
• KimISJeongYIKimSHSelf-assembled hydrogel nanoparticles composed of dextran and poly(ethylene glycol) macromerInt J Pharmacol2000205109116
   Google Scholar
• JanaSMajiNNayakAKSenKKBasuSKDevelopment of chitosan-based nanoparticles through inter-polymeric complexation for oral drug deliveryCarbohydr Polym201398187087623987423
   PubMed Web of Science ®Google Scholar
• TomoyasuYYasudaTMaedaSHiguchiHMiyawakiTLiposome-encapsulated midazolam for oral administrationJ Lipososome Res2011212166172
   PubMed Web of Science ®Google Scholar
• PatelKPadhyeSNagarsenkerMDuloxetine HCl lipid nanoparticles: preparation, characterization, and dosage form designAAPS PharmSciTech201213112513322167415
   PubMed Web of Science ®Google Scholar
• GaneshMHemalathaPMeiPMRajasekarKJangHTA new fluoride mediated synthesis of mesoporous silica and their usefulness in controlled delivery of duloxetine hydrochloride a serotonin re-uptake inhibitorJ Ind Eng Chem2012182684689
   Web of Science ®Google Scholar
• ZhouYZhangGRaoZIncreased brain uptake of venlafaxine loaded solid lipid nanoparticles by overcoming the efflux function and expression of P-gpArch Pharm Res20153871325133525567760
   PubMed Web of Science ®Google Scholar
• ShahSPalAKaushikVKDeviSPreparation and characterization of venlafaxine hydrochloride-loaded chitosan nanoparticles and in vitro release of drugJ Appl Polym Sci2009112528762887
   Web of Science ®Google Scholar
• YangHLopinaSTExtended release of a novel antidepressant, venlafaxine, based on anionic polyamidoamine dendrimers and poly(ethylene glycol)-containing semi-interpenetrating networksJ Biomed Mater Res A200572110711415543595
   PubMedGoogle Scholar
• ChildsSLChyallLJDunlapJTSmolenskayaVNStahlyBCStahlyGPCrystal engineering approach to forming cocrystals of amine hydrochlorides with organic acids. Molecular complexes of fluoxetine hydrochloride with benzoic, succinic, and fumaric acidsJ Am Chem Soc200412641133351334215479089
   PubMed Web of Science ®Google Scholar
• VarshosazJTabbakhianMMohammadiMYFormulation and optimization of solid lipid nanoparticles of buspirone HCl for enhance ment of its oral bioavailabilityJ Liposome Res201020428629619958118
   PubMed Web of Science ®Google Scholar
• GaoBWangJWangDA novel preparation method for drug nanocrystals and characterization by ultrasonic spray-assisted electrostatic adsorptionInt J Nanomedicine201383927393624143097
   PubMed Web of Science ®Google Scholar
• YanYChenJMGengNLuTBImproving the solubility of agomelatine via cocrystalsCryst Growth Des201212522262233
   Web of Science ®Google Scholar
• HeXLZhuYJWangMJingGXZhuRRWangSLAntidepressant effects of curcumin and HU-211 coencapsulated solid lipid nanoparticles against corticosterone-induced cellular and animal models of major depressionInt J Nanomedicine2016114975499027757031
   PubMed Web of Science ®Google Scholar
• QinJYangXMiJEnhanced antidepressant-like effects of the macromolecule trefoil factor 3 by loading into negatively charged liposomesInt J Nanomedicine201495247525725419129
   PubMed Web of Science ®Google Scholar
• QinJYangXZhangRXMonocyte mediated brain targeting delivery of macromolecular drug for the therapy of depressionNanomedicine201511239140025461282
   PubMed Web of Science ®Google Scholar
• HuangCTTsaiMJLinYHEffect of microemulsions on transdermal delivery of citalopram: optimization studies using mixture design and response surface methodologyInt J Nanomedicine201382295230423919086
   PubMed Web of Science ®Google Scholar
• WeiXLHanYRQuanLHLiuCYLiaoYHOily nanosuspension for long-acting intramuscular delivery of curcumin didecanoate prodrug: preparation, characterization and in vivo evaluationEur J Pharm Sci201349228629323542494
   PubMed Web of Science ®Google Scholar
• GrabruckerAMGarnerCCBoeckersTMDevelopment of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidencesPLoS One201163e1785121448455
   PubMed Web of Science ®Google Scholar
• Lifestyles TeamStatistics on Sexual and Reproductive Health Services England 2015/16 [webpage on the Internet] Available from: http://www.content.digital.nhs.uk/catalogue/PUB21969/srh-serv-eng-15-16-rep.pdfAccessed February 21, 2017
   Google Scholar
• GauravCGoutamRRohanKNSwetaKTAbhayCSAmitGK(Copper-curcumin) beta-cyclodextrin vaginal gel: Delivering a novel metal-herbal approach for the development of topical contraception prophylaxisEur J Pharm Sci20146518319125266573
   PubMed Web of Science ®Google Scholar
• LiuHFLiuZLXieCSYuJZhuCHThe antifertility effectiveness of copper/low-density polyethylene nanocomposite and its influence on the endometrial environment in ratsContraception200775215716117241847
   PubMed Web of Science ®Google Scholar
• YuJLiJLiHGLiJXXieCSZhuCHComparative study on contraceptive efficacy and clinical performance of the copper/low-density polyethylene nanocomposite IUD and the copper T220C IUDContraception200878431932318847581
   PubMed Web of Science ®Google Scholar
• NandedkarTDSagvekarPThakurBPolymeric nanoparticle formulation of octapeptide (NP-OP): in vitro release and in vivo effect in common marmosets, Callithrix jacchus LinnIndian J Exp Biol201351121055106224579370
   PubMed Web of Science ®Google Scholar
• BoonthumCNamdeeKBoonrungsimanSChitosan-based DNA delivery vector targeted to gonadotropin-releasing hormone (GnRH) receptorCarbohydr Polym201715731132027987933
   PubMed Web of Science ®Google Scholar
• JhaRKJhaPKGuhaSKSmart RISUG: a potential new contraceptive and its magnetic field-mediated sperm interactionInt J Nanomedicine200941556419421370
   PubMed Web of Science ®Google Scholar
• GuhaSKSinghGAnandSAnsariSKumarSKoulVPhase-I clinical-trial of an injectable contraceptive for the maleContraception19934843673758222664
   PubMed Web of Science ®Google Scholar
• GuhaSKSinghGAnsariSPhase II clinical trial of a vas deferens injectable contraceptive for the maleContraception19975642452509408706
   PubMed Web of Science ®Google Scholar
• ChakiSPDasHCMisroMMA short-term evaluation of semen and accessory sex gland function in phase III trial subjects receiving intravasal contraceptive RISUGContraception2003671737812521662
   PubMed Web of Science ®Google Scholar
• MarfatiaYSPandyaIMehtaKCondoms: past, present, and futureIndian J Sexual Transm Dis2015362133139
   Google Scholar
• FayazAMAoZJGirilalMInactivation of microbial infectiousness by silver nanoparticles-coated condom: a new approach to inhibit HIV- and HSV-transmitted infectionInt J Nanomedicine201275007501823049252
   PubMed Web of Science ®Google Scholar
• BanerjeeSGuhaSKRISUG (R): a potential candidate for the entry inhibitor group of antiretroviral drugsMed Hypotheses200973215015219409721
   PubMed Web of Science ®Google Scholar
• KirwanPDChauCBrownAEGillONDelpechVCHIV in the UK – 2016 report [webpage on the Internet]Public Health EnglandLondon122016 Available from: http://judahtrust.org/HIV_in_the_UK_2016.pdfAccessed February 23, 2017
   Google Scholar
• MamoTMosemanEAKolishettiNEmerging nanotechnology approaches for HIV/AIDS treatment and preventionNanomedicine20105226928520148638
   PubMed Web of Science ®Google Scholar
• RoyURodriguezJBarberPdas NevesJSarmentoBNairMThe potential of HIV-1 nanotherapeutics: from in vitro studies to clinical trialsNanomedicine201510243597360926400459
   PubMed Web of Science ®Google Scholar
• Bioavailability of MK-1439 Experimental Nano Formulations in Healthy Adults (MK-1439-046) [webpage on the Internet]Bethesda, MDNational Library of Medicine (US) Identifier NCT02549040; September 11, 2015[cited February 4, 2016]. Available from: https://clinicaltrials.gov/ct2/show/NCT02549040?term=nano&draw=1&rank=27Accessed August 1, 2017
   Google Scholar
• PK of Efavirenz & Lopinavir Nano-formulations in Healthy Volunteers [webpage on the Internet]Bethesda (MD)National Library of Medicine (US) Identifier NCT02631473; December 6, 2016. Available from: https://clinicaltrials.gov/ct2/show/NCT02631473?term=NCT02631473&rank=1Accessed August 1, 2017
   Google Scholar
• Phase II safety and acceptability of an investigational injectable product, TMC278LA, for pre-exposure prophylaxis (TMC278LA) [webpage on the Internet]Bethesda (MD)National Library of Medicine (US) Identifier NCT02165202; May 21, 2014[cited March 31, 2017]. Available from: https://clinicaltrials.gov/ct2/show/NCT02165202Accessed April 3, 2017
   Google Scholar
• Study to evaluate the safety tolerability and acceptability of long acting injections of the human immunodeficiency virus (HIV) integrase inhibitor, GSK1265744, in HIV Uninfected Men (ECLAIR) [webpage on the Internet]Bethesda (MD)National Library of Medicine (US) Identifier NCT02076178; February 27, 2014[cited November 23, 2016]. Available from: https://clinicaltrials.gov/ct2/show/NCT02076178Accessed February 21, 2017
   Google Scholar
• RodriguezBAsmuthDMMatiningRMSafety, tolerability, and immunogenicity of repeated doses of DermaVir, a candidate therapeutic HIV vaccine, in HIV-Infected patients receiving combination antiretroviral therapy: results of the ACTG 5176 trialJ Acquir Immune Defic Syndr201364435135924169120
   PubMed Web of Science ®Google Scholar
• CaronMBessonGEtennaSLDProtective properties of non-nucleoside reverse transcriptase inhibitor (MC1220) incorporated into liposome against intravaginal challenge of Rhesus Macaques with RT-SHIVVirology2010405122523320591460
   PubMed Web of Science ®Google Scholar
• KovarovaMCouncilODDateAANanoformulations of rilpivirine for topical pericoital and systemic coitus-independent administration efficiently prevent HIV transmissionPLoS Pathog2015118e100507526271040
   PubMed Web of Science ®Google Scholar
• LeeJHOhBKChoiJWDevelopment of a HIV-1 virus detection system based on nanotechnologySensors20151559915992725923937
   PubMed Web of Science ®Google Scholar
• SmithJSLindsayLHootsBHuman papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis updateInt J Cancer2007121362163217405118
   PubMed Web of Science ®Google Scholar
• Howell-JonesRBaileyABeddowsSMulti-site study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in EnglandBr J Cancer2010103220921620628396
   PubMed Web of Science ®Google Scholar
• GarlandSMHernandez-AvilaMWheelerCMQuadrivalent vaccine against human papillomavirus to prevent anogenital diseasesN Engl J Med2007356191928194317494926
   PubMed Web of Science ®Google Scholar
• VillaLLPerezGKjaerSKQuadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesionsN Engl J Med2007356191915192717494925
   PubMed Web of Science ®Google Scholar
• PaavonenJJenkinsDBoschFXEfficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trialLancet200736995802161217017602732
   PubMed Web of Science ®Google Scholar
• HerreroRHildesheimARodriguezACRationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa RicaVaccine200826374795480818640170
   PubMed Web of Science ®Google Scholar
• FoldvariMHPV infections: can they be eradicates using nanotechnology?Nanomedicine2012813113522101106
   PubMed Web of Science ®Google Scholar
• FoldvariMBadeaIKumarPBiphasic vesicles for topical delivery of interferon alpha in human volunteers and treatment of patients with human papillomavirus infectionsCurr Drug Deliv20118330731921291377
   PubMed Web of Science ®Google Scholar
• FriasIAMAvelinoKSilvaRRAndradeCASOliveiraMDLTrends in biosensors for HPV: identification and diagnosisJ Sensors20152015913640
   Web of Science ®Google Scholar
• Public Health EnglandSexually transmitted infections and chlamydia screening in England [webpage on the Internet]2015 Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/617025/Health_Protection_Report_STIs_NCSP_2017.pdfAccessed March 3, 2017
   Google Scholar
• LiuYREgilmezNKRussellMWEnhancement of adaptive immunity to Neisseria gonorrhoeae by local Iintravaginal administration of microencapsulated interleukin 12J Infect Dis2013208111821182924048962
   PubMed Web of Science ®Google Scholar
• SinghRVermaRSumanaGNanobiocomposite platform based on polyaniline-iron oxide-carbon nanotubes for bacterial detectionBioelectrochemistry201286303722306338
   PubMed Web of Science ®Google Scholar
• SinghRVermaRKaushikAChitosan-iron oxide nanocomposite platform for mismatch-discriminating DNA hybridization for Neisseria gonorrhoeae detection causing sexually transmitted diseaseBiosens Bioelectron20112662967297421190837
   PubMed Web of Science ®Google Scholar
• RautaPRDasNMNayakDAsheSNayakBEnhanced efficacy of clindamycin hydrochloride encapsulated in PLA/PLGA based nanoparticle system for oral deliveryIET Nanobiotechnol201610425426127463797
   PubMed Web of Science ®Google Scholar
• FairleySJSinghSRYilmaANChlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccineInt J Nanomedicine201382085209923785233
   PubMed Web of Science ®Google Scholar
• DixitSSinghSRYilmaANAgeeRDTahaMDennisVAPoly(lactic acid)-poly(ethylene glycol) nanoparticles provide sustained delivery of a Chlamydia trachomatis recombinant MOMP peptide and potentiate systemic adaptive immune responses in miceNanomedicine20141061311132124602605
   PubMed Web of Science ®Google Scholar
• CambridgeCDSinghSRWaffoABFairleySJDennisVAFormulation, characterization, and expression of a recombinant MOMP Chlamydia trachomatis DNA vaccine encapsulated in chitosan nanoparticlesInt J Nanomedicine201381759177123690681
   PubMed Web of Science ®Google Scholar
• MishraMKKottaKHaliMPAMAM dendrimer-azithromycin conjugate nanodevices for the treatment of Chlamydia trachomatis infectionsNanomedicine20117693594421658474
   PubMed Web of Science ®Google Scholar
• YilmaANSinghSRDixitSDennisVAAnti-inflammatory effects of silver-polyvinyl pyrrolidone (Ag-PVP) nanoparticles in mouse macrophages infected with live Chlamydia trachomatisInt J Nanomedicine201382421243223882139
   PubMed Web of Science ®Google Scholar
• StaryGOliveARadovic-MorenoAFA mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cellsScience20153486241aaa820526089520
   PubMed Web of Science ®Google Scholar
• TangJFXuZHZhouLQinHWangYFWangHHRapid and simultaneous detection of Ureaplasma parvum and Chlamydia trachomatis antibodies based on visual protein microarray using gold nanoparticles and silver enhancementDiagn Microbiol Infect Dis201067212212820207096
   PubMed Web of Science ®Google Scholar
• YangHLiDHeRA novel quantum dots-based point of care test for syphilisNanoscale Res Lett20105587588120672123
   PubMed Web of Science ®Google Scholar
• TangZLiangZSNongYWuXCLuoHGaoKApplication of Goldmag immune probe in timely detection of syphilis based on GIS platformArtif Cell Nanomed Biotechnol2017453460466
   PubMed Web of Science ®Google Scholar
• YangDMaJZhangQPolyelectrolyte-coated gold magnetic nanoparticles for immunoassay development: toward point of care diagnostics for syphilis screeningAnal Chem201385146688669523735054
   PubMed Web of Science ®Google Scholar
• DunselmanGAJVermeulenNBeckerCESHRE guideline: management of women with endometriosisHum Reprod201429340041224435778
   PubMed Web of Science ®Google Scholar
• PolatMYIBoynukalinKYaraiHIn vitro fertilization for endometriosis-associated infertilityWomens Health (Lond)201511563364126395161
   PubMedGoogle Scholar
• HueJJLeeHJJonSDistribution and accumulation of Cy5.5-labeled thermally cross-linked superparamagnetic iron oxide nanoparticles in the tissues of ICR miceJ Vet Sci201314447347924366671
   PubMed Web of Science ®Google Scholar
• ZhangHLiJCSunWJHyaluronic acid-modified magnetic iron oxide nanoparticles for MR Imaging of surgically induced endometriosis model in ratsPLoS One201494e9471824722347
   PubMed Web of Science ®Google Scholar
• ZhaoMDSunYMFuGFGene therapy of endometriosis introduced by polymeric micelles with glycolipid-like structureBiomaterials201233263464321996531
   PubMed Web of Science ®Google Scholar
• ChaudhuryKBabuKNSinghAKDasSKumarASealSMitigation of endometriosis using regenerative cerium oxide nanoparticlesNanomedicine20139343944822960424
   PubMed Web of Science ®Google Scholar
• JiangJBischofJEffect of timing, dose and interstitial versus nanoparticle delivery of tumor necrosis factor alfa in combinatorial adjuvant cryosurgery treatment of ELT-3 uterine fibroid timorCryoletters2010311506220309509
   PubMed Web of Science ®Google Scholar
• AliHKGVincentKMotamediMRyttingENanomedicine for uterine leiomyoma therapyTher Deliv20134216117523343157
   PubMedGoogle Scholar
• ShalabySMKhaterMKPeruchoAMMagnetic nanoparticles as a new approach to improve the efficacy of gene therapy against differentiated human uterine fibroid cells and tumor-initiating stem cellsFertil Steril20161056163827020169
   PubMed Web of Science ®Google Scholar
• Office for National StatisticsStatistical Bulletin: Cancer Registration Statistics [webpage on the Internet]EnglandFirst Release2015 Available from: https://www.ons.gov.uk/peoplepopulationand-community/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/firstrelease2015Accessed February 21, 2017
   Google Scholar
• WangXYangLLChenZShinDMApplication of nanotechnology in cancer therapy and imagingCA Cancer J Clin20085829711018227410
   PubMed Web of Science ®Google Scholar
• Beeghly-FadielAKataokaNShuXOHer-2/neu amplification and breast cancer survival: results from the Shanghai breast cancer studyOncol Rep20081951347135418425397
   PubMed Web of Science ®Google Scholar
• ArtemovDMoriNOkollieBBhujwallaZMMR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticlesMagnet Res Med2003493403408
   PubMed Web of Science ®Google Scholar
• YangHMParkCWWooMAHER2/neu antibody conjugated poly(amino acid)-coated iron oxide nanoparticles for breast cancer MR imagingBiomacromolecules201011112866287220932000
   PubMed Web of Science ®Google Scholar
• ChenHWangLYuQAnti-HER2 antibody and ScFvEGFR-conjugated antifouling magnetic iron oxide nanoparticles for targeting and magnetic resonance imaging of breast cancerInt J Nanomedicine201383781379424124366
   PubMed Web of Science ®Google Scholar
• PopovtzerRAgarwalAKotovNATargeted gold nanoparticles enable molecular CT imaging of cancerNano Lett2008812459319367807
   PubMed Web of Science ®Google Scholar
• LowPSKularatneSAFolate-targeted therapeutic and imaging agents for cancerCurr Opin Chem Biol200913325626219419901
   PubMed Web of Science ®Google Scholar
• ZhangHLiJCHuYShenMWShiXYZhangGFFolic acid-targeted iron oxide nanoparticles as contrast agents for magnetic resonance imaging of human ovarian cancerJ Ovarian Res201691927025582
   PubMed Web of Science ®Google Scholar
• ZhouBQYangJPengCPEGylated polyethylenimine-entrapped gold nanoparticles modified with folic acid for targeted tumor CT imagingCol Surf B2016140489496
   PubMed Web of Science ®Google Scholar
• XiLSatpathyMZhaoQQianWYangLJiangHHER-2/neu targeted delivery of a nanoprobe enables dual photoacoustic and fluorescence tomography of ovarian cancerNanomedicine201410366967724269306
   PubMed Web of Science ®Google Scholar
• NidaDLRahmanMSCarlsonKDRichards-KortumRFollenMFluorescent nanocrystals for use in early cervical cancer detectionGynecol Oncol2005993 Suppl 1S89S9416139342
   PubMed Web of Science ®Google Scholar
• PalantavidaSGuzNVWoodworthCDSokolovIUltrabright fluorescent mesoporous silica nanoparticles for prescreening of cervical cancerNanomedicine2013981255126223665420
   PubMed Web of Science ®Google Scholar
• LiuWNieLLiFFolic acid conjugated magnetic iron oxide nanoparticles for nondestructive separation and detection of ovarian cancer cells from whole bloodBiomater Sci20164115916626478922
   PubMed Web of Science ®Google Scholar
• KimDJChoiMKJeongJTEnhancement of capture sensitivity for circulating tumor cells in a breast cancer patient’s blood by silicon nanowire platformJ Biomed Nanotechnol201612464565527301191
   PubMed Web of Science ®Google Scholar
• JoHHerJBanCDual aptamer-functionalized silica nanoparticles for the highly sensitive detection of breast cancerBiosens Bioelectron20157112913625897882
   PubMed Web of Science ®Google Scholar
• NieblingMGPleijhuisRGBastiaannetEBrouwersAHvan DamGMHoekstraHJA systematic review and meta-analyses of sentinel lymph node identification in breast cancer and melanoma, a plea for tracer mappingEur J Surg Oncol201642446647326853759
   PubMed Web of Science ®Google Scholar
• AlboDWayneJDHuntKKAnaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancerAm J Surg2001182439339811720678
   PubMed Web of Science ®Google Scholar
• WuXLinQChenGSentinel lymph node detection using carbon nanoparticles in patients with early breast cancerPLoS One2015108e013571426296136
   PubMed Web of Science ®Google Scholar
• KimSJBaePKChungBHSelf-assembled levan nanoparticles for targeted breast cancer imagingChem Commun (Camb)201551110711025383444
   PubMed Web of Science ®Google Scholar
• GengFSongKXingJZThio-glucose bound gold nanoparticles enhance radio-cytotoxic targeting of ovarian cancerNanotechnology20112228510121654036
   PubMed Web of Science ®Google Scholar
• Kaitu’u-LinoTJPattisonSYeLTargeted nanoparticle delivery of doxorubicin into placental tissues to treat ectopic pregnanciesEndocrinology201315491191923288908
   PubMed Web of Science ®Google Scholar
• SolomonBJDesaiJRosenthalMA first-time-in-human phase I clinical trial of bispecific antibody-targeted, paclitaxel-packaged bacterial minicellsPLoS One20151012e014455926659127
   PubMed Web of Science ®Google Scholar
• MinionLEChaseDMFarleyJHWillmottLJMonkBJSafety and efficacy of salvage nano-particle albumin bound paclitaxel in recurrent cervical cancer: a feasibility studyGynecol Oncol Res Pract20163427231575
   PubMedGoogle Scholar
• ZongYWuJShenKNanoparticle albumin-bound paclitaxel as neoadjuvant chemotherapy of breast cancer: a systematic review and meta-analysisOncotarget2017810173601737228061451
   PubMedGoogle Scholar
• ZhangXChenJKangYTargeted paclitaxel nanoparticles modified with follicle-stimulating hormone beta 81-95 peptide show effective antitumor activity against ovarian carcinomaInt J Pharm201345349850523811008
   PubMed Web of Science ®Google Scholar
• LiangCYangYLingYHuangYLiTLiXImproved therapeutic effect of folate-decorated PLGA-PEG nanoparticles for endometrial carcinomaBioorg Med Chem2011194057406621641806
   PubMed Web of Science ®Google Scholar
• LiuBHanLLiuJHanSChenZJiangLCo-delivery of paclitaxel and TOS-cisplatin via TAT-targeted solid lipid nanoparticles with synergistic antitumor activity against cervical cancerInt J Nanomedicine20171295596828203075
   PubMed Web of Science ®Google Scholar
• LiJShenZMaXNeuropeptide Y Y1 receptors meditate targeted delivery of anticancer drug with encapsulated nanoparticles to breast cancer cells with high selectivity and its potential for breast cancer therapyACS Appl Mater Interfaces2015795574558225695533
   PubMed Web of Science ®Google Scholar
• PeetlaCVijayaraghavaluSLabhasetwarVBiophysics of cell membrane lipids in cancer drug resistance: implications for drug transport and drug delivery with nanoparticlesAdv Drug Deliv Rev20136513–141686169824055719
   PubMed Web of Science ®Google Scholar
• RobertsCMShahinSAWenWNanoparticle delivery of siRNA against TWIST to reduce drug resistance and tumor growth in ovarian cancer modelsNanomedicine201713396597627890656
   PubMed Web of Science ®Google Scholar
• WinerIWangSLeeYEF3-targeted cisplatin-hydrogel nanoparticles as an effective therapeutic that targets both murine and human ovarian tumor endothelial cells in vivoCancer Res201070218674868320959470
   PubMed Web of Science ®Google Scholar
• WangLJiaEOvarian cancer targeted hyaluronic acid-based nanoparticle system for paclitaxel delivery to overcome drug resistanceDrug Deliv20162351810181726530693
   PubMed Web of Science ®Google Scholar
• YangYHeLLiuYPromising nanocarriers for PEDF gene targeting delivery to cervical cancer cells mediated by the overexpressing FRαSci Rep201663242727576898
   PubMed Web of Science ®Google Scholar
• NayakASatapathySRDasDNanoquinacrine induced apoptosis in cervical cancer stem cells through the inhibition of hedgehog-GLI1 cascade: Role of GLI-1Sci Rep201662060026846872
   PubMed Web of Science ®Google Scholar
• LiLWangLXiaoSLiYChengCXueMEffect of nano-realgar on proliferation and apoptosis of human cervical carcinoma cellsZhong Nan Da Xue Xue Bao Yi Xue Ban2015401010681075 Chinese26541839
   PubMedGoogle Scholar
• ZhangXFGurunathanSCombination of salinomycin and silver nanoparticles enhances apoptosis and autophagy in human ovarian cancer cells: an effective anticancer therapyInt J Nanomedicine2016113655367527536105
   PubMed Web of Science ®Google Scholar
• LongQDXieYHuangYQInduction of apoptosis and inhibition of angiogenesis by PEGylated liposomal quercetin in both cisplatin-sensitive and cisplatin-resistant ovarian cancersJ Biomed Nanotechnol2013996597523858960
   PubMed Web of Science ®Google Scholar
• Herrera EstradaLPadmoreTJChampionJABacterial effector nanoparticles as breast cancer therapeuticsMol Pharm201613371071926800341
   PubMedGoogle Scholar
• YuMZPangWHYangTSystemic delivery of siRNA by T7 peptide modified core-shell nanoparticles for targeted therapy of breast cancerEur J Pharm Sci201692394827355138
   PubMed Web of Science ®Google Scholar
• YangJLiSGuoFZhangWWangYPanYInduction of apoptosis by chitosan/HPV16 E7 siRNA complexes in cervical cancer cellsMol Med Rep20137998100223258711
   PubMed Web of Science ®Google Scholar
• ZhengYChenHZengXSurface modification of TPGS-b-(PCL-ran-PGA) nanoparticles with polyethyleneimine as a co-delivery system of TRAIL and endostatin for cervical cancer gene therapyNanoscale Res Lett20138116123570619
   PubMedGoogle Scholar
• QiXSongXLiuPAntitumor effects of PLGA nanoparticles encapsulating the human PNAS-4 gene combined with cisplatin in ovarian cancerOncol Rep20112670371021667029
   PubMed Web of Science ®Google Scholar
• LuoLDuTZhangJEfficient inhibition of ovarian cancer by degradable nanoparticle-delivered survivin T34A geneInt J Nanomedicine20161150151226893558
   PubMed Web of Science ®Google Scholar
• JingtingCHuiningLYiZPreparation and characterization of magnetic nanoparticles containing Fe(3)O(4)-dextran-anti-β-human chorionic gonadotropin, a new generation choriocarcinoma-specific gene vectorInt J Nanomedicine2011628529421383853
   PubMed Web of Science ®Google Scholar
• HuiningLYiZDihongTInhibition of choriocarcinoma by Fe3O4-dextran-anti-β-human chorionic gonadotropin nanoparticles containing antisense oligodeoxynucleotide of heparanaseInt J Nanomedicine201384371437824235832
   PubMed Web of Science ®Google Scholar
• GradyDManagement of menopausal symptomsN Engl J Med2006355222338234717135587
   PubMed Web of Science ®Google Scholar
• CauleyJARobbinsJChenZEffects of estrogen plus progestin on risk of fracture and bone mineral density – the Women’s Health Initiative randomized trialJ Am Med Assoc20032901317291738
   PubMed Web of Science ®Google Scholar
• RossouwJEAndersonGLPrenticeRLRisks and benefits of estrogen plus progestin in healthy postmenopausal women – principal results from the Women’s Health Initiative randomized controlled trialJ Am Med Assoc20022883321333
   PubMed Web of Science ®Google Scholar
• AndersonGLLimacherMAssafAREffects of conjugated, equine estrogen in postmenopausal women with hysterectomy – the Women’s Health Initiative randomized controlled trialJ Am Med Assoc20042911417011712
   PubMed Web of Science ®Google Scholar
• HaasJSKaplanCPGerstenbergerEPKerlikowskeKChanges in the use of postmenopausal hormone therapy after the publication of clinical trial resultsAnn Intern Med2004140318418814757616
   PubMed Web of Science ®Google Scholar
• CanonicoMOgerEPlu-BureauGHormone therapy and venous thromboembolism among postmenopausal women – impact of the route of estrogen administration and progestogens: the ESTHER studyCirculation2007115784084517309934
   PubMed Web of Science ®Google Scholar
• RenouxCDell’AnielloSGarbeESuissaSTransdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control studyBMJ2010340c251920525678
   PubMed Web of Science ®Google Scholar
• SimonJAESTRASORB Study GroupEstradiol in micellar nanoparticles: the efficacy and safety of a novel transdermal drug-delivery technology in the management of moderate to severe vasomotor symptomsMenopause200613222223116645536
   PubMed Web of Science ®Google Scholar
• ValenzuelaPSimonJANanoparticle delivery for transdermal HRTMaturitas2012731748022325243
   PubMed Web of Science ®Google Scholar
• Nanoparticulate Versus Micronized Steroids Delivery for Transdermal Hormone Replacement Therapy (Nanoparticle) [webpage on the Internet]Bethesda (MD)National Library of Medicine (US) Identifier NCT02467673, June 7, 2015[cited May 21, 2016]. Available from: https://clinicaltrials.gov/ct2/show/NCT02467673?term=nano&draw=1&rank=59Accessd August 1, 2017
   Google Scholar
• BotelhoMAQueirozDBSilvaIMicronized versus nanoparticles in transdermal hormone replacement therapy: effects on blood pressure and inflammatory parameters in Brazilian postmenopausal womenMed-Crave Group LLC6132017 Available from: http://medcraveonline.com/ebooks/Micronized_Versus_Nanoparticles_in_Transdermal_Hormone_Replacement_Therapy_Effects_on_Blood_Pressure_and_Inflammatory_Parameters_in_Brazilian_Postmenopausal_Women.pdfAccessed August 1, 2017
   Google Scholar
• MazaheriMEslahiNOrdikhaniFTamjidESimchiANanomedicine applications in orthopedic medicine: state of the artInt J Nanomedicine2015106039605326451110
   PubMed Web of Science ®Google Scholar
• Roohani-EsfahaniSIZreiqatHNanoparticles: a promising new therapeutic platform for bone regeneration?Nanomedicine (Lond)20171241942228181460
   PubMed Web of Science ®Google Scholar
• KhajuriaDKDishaCVasireddiRRazdanRMahapatraDRRisedronate/zinc-hydroxyapatite based nanomedicine for osteoporosisMater Sci Eng C Mater Biol Appl201663788727040198
   PubMed Web of Science ®Google Scholar
• LeeMSSuCMYehJCWuPRTsaiTYLouSLSynthesis of composite magnetic nanoparticles Fe3O4 with alendronate for osteoporosis treatmentInt J Nanomedicine2016114583459427695319
   PubMed Web of Science ®Google Scholar
• HwangSRSeoDHByunYParkJWPreparation and in vivo evaluation of an orally available enteric-microencapsulated parathyroid hormone (1-34)-deoxycholic acid nanocomplexInt J Nanomedicine2016114231424627621618
   PubMed Web of Science ®Google Scholar
• PsarrosCLeeRMargaritisMAntoniadesCNanomedicine for the prevention, treatment and imaging of atherosclerosisMaturitas2012731526022261366
   PubMed Web of Science ®Google Scholar
• JonerMMorimotoKKasukawaHSite-specific targeting of nanoparticle Prednisolone reduces in-stent restenosis in a rabbit model of established atheromaArterioscler Thromb Vasc Biol200828111960196618688017
   PubMed Web of Science ®Google Scholar
• ChonoSTauchiYDeguchiYMorimotoKEfficient drug delivery to atherosclerotic lesions and the antiatherosclerotic effect by dexamethasone incorporated into liposomes in atherogenic miceJ Drug Target200513426727616051539
   PubMed Web of Science ®Google Scholar
• ChnariELariHBTianLUhrichKEMoghePVNanoscale anionic macromolecules for selective retention of low-density lipoproteinsBiomaterials200526173749375815621265
   PubMed Web of Science ®Google Scholar
• XiaoLAoshimaHSaitohYMiwaNHighly hydroxylated fullerene localizes at the cytoskeleton and inhibits oxidative stress in adipocytes and a subcutaneous adipose-tissue equivalentFree Radic Biol Med20115171376138921684329
   PubMed Web of Science ®Google Scholar
• WinterPMNeubauerAMCaruthersSDEndothelial alpha(v) beta(3) integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosisArterioscler Thromb Vasc Biol20062692103210916825592
   PubMed Web of Science ®Google Scholar
• McCarthyJRJafferFAWeisslederRA macrophage-targeted theranostic nanoparticle for biomedical applicationsSmall200628–998398717193154
   PubMed Web of Science ®Google Scholar
• Alzheimer’s ResearchUKWomen and dementia: a marginalised majority32015 Available from: http://www.alzheimersre-searchuk.org/wp-content/uploads/2015/03/Women-and-Dementia-A-Marginalised-Majority1.pdfAccessed June 8, 2017
   Google Scholar
• Alzheimer’s AssociationAlzheimer’s Disease Facts and Figures, Alzheimer’s & Dementia922013 Available from: http://www.alz.org/downloads/facts_figures_2013.pdfAccessed September 8, 2017
   Google Scholar
• BrambillaDLe DroumaguetBNicolasJNanotechnologies for Alzheimer’s disease: diagnosis, therapy, and safety issuesNanomedicine20117552154021477665
   PubMed Web of Science ®Google Scholar
• WadghiriYZSigurdssonEMSadowskiMDetection of Alzheimer’s amyloid in transgenic mice using magnetic resonance microimagingMagn Reson Med200350229330212876705
   PubMed Web of Science ®Google Scholar
• SkaatHMargelSSynthesis of fluorescent-maghemite nanoparticles as multimodal imaging agents for amyloid-beta fibrils detection and removal by a magnetic fieldBiochem Biophys Res Commun2009386464564919559008
   PubMed Web of Science ®Google Scholar
• ZhouJTFaHBYinWSynthesis of superparamagnetic iron oxide nanoparticles coated with a DDNP-carboxyl derivative for in vitro magnetic resonance imaging of Alzheimer’s diseaseMater Sci Eng C Mater Biol Appl20143734835524582259
   PubMed Web of Science ®Google Scholar
• LeeSSLeeLPNoninvasive label-free nanoplasmonic optical imaging for real-time monitoring of in vitro amyloid fibrogenesisNanoscale2014673561356524598888
   PubMed Web of Science ®Google Scholar
• ChoiJSChoiHJJungDCLeeJHCheonJNanoparticle assisted magnetic resonance imaging of the early reversible stages of amyloid beta self-assemblyChem Commun (Camb)20081921972199
   Google Scholar
• SiegemundTPaulkeBRSchmiedelHThioflavins released from nanoparticles target fibrillar amyloid beta in the hippocampus of APP/PS1 transgenic miceInt J Dev Neurosci2006242–319520116386399
   PubMed Web of Science ®Google Scholar
• TokurakuKMarquardtMIkezuTReal-time imaging and quantification of amyloid-beta peptide aggregates by novel quantum-dot nanoprobesPLoS One2009412e849220041162
   PubMed Web of Science ®Google Scholar
• FengLLongHYLiuRKA quantum dot probe conjugated with a beta antibody for molecular imaging of Alzheimer’s disease in a mouse modelCell Mol Neurobiol201333675976523695800
   PubMed Web of Science ®Google Scholar
• GeorganopoulouDGChangLNamJMNanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer’s diseaseProc Natl Acad Sci U S A200510272273227615695586
   PubMed Web of Science ®Google Scholar
• ChikaeMFukudaTKermanKIdegamiKMiuraYTamiyaEAmyloid-beta detection with saccharide immobilized gold nanoparticle on carbon electrodeBioelectrochemistry200874111812318676183
   PubMed Web of Science ®Google Scholar
• KangDYLeeJHOhBKChoiJWUltra-sensitive immunosensor for beta-amyloid (1-42) using scanning tunneling microscopy-based electrical detectionBiosens Bioelectron20092451431143618829296
   PubMed Web of Science ®Google Scholar
• StegurovaLDraberovaEBartosADraberPRipovaDDraberPGold nanoparticle-based immuno-PCR for detection of tau protein in cerebrospinal fluidJ Immunol Methods201440613714224642424
   PubMed Web of Science ®Google Scholar
• NeelyAPerryCVarisliBUltrasensitive and highly selective detection of Alzheimer’s disease biomarker using two-photon Rayleigh scattering properties of gold nanoparticleACS Nano2009392834284019691350
   PubMed Web of Science ®Google Scholar
• SrikanthMKesslerJANanotechnology – novel therapeutics for CNS disordersNat Rev Neurol20128630731822526003
   PubMed Web of Science ®Google Scholar
• RitchieCWBushAIMackinnonAMetal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting A beta amyloid deposition and toxicity in Alzheimer disease – a pilot phase 2 clinical trialArch Neurol200360121685169114676042
   PubMed Web of Science ®Google Scholar
• CuiZLockmanPRAtwoodCSNovel D-penicillamine carrying nanoparticles for metal chelation therapy in Alzheimer’s and other CNS diseasesEur J Pharm Biopharm200559226327215661498
   PubMed Web of Science ®Google Scholar
• MarambaudPVingtdeuxVGilibertoLDaviesPResveratrol lowers beta-amyloid accumulation and deposition in vivo by controlling AMPK signalingAlzheimers Dement201064S406
   Google Scholar
• PaiASRubinsteinIOnyukselHPEGylated phospholipid nanomicelles interact with beta-amyloid((1-42)) and mitigate its beta-sheet formation, aggregation and neurotoxicity in vitroPeptides200627112858286616762454
   PubMed Web of Science ®Google Scholar
• KumaraswamyPSethuramanSKrishnanUMLiposomal delivery of a beta sheet blocker peptide for the treatment of Alzheimer’s diseaseAlzheimers Dement201284 SupplP705
   Google Scholar
• IkedaKOkadaTSawadaSAkiyoshiKMatsuzakiKInhibition of the formation of amyloid beta-protein fibrils using biocompatible nanogels as artificial chaperonesFEBS Lett200658028–296587659517125770
   PubMed Web of Science ®Google Scholar
• TaylorMMooreSMourtasSEffect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer’s A beta peptideNanomedicine20117554155021722618
   PubMed Web of Science ®Google Scholar
• MourtasSLazarANMarkoutsaEDuyckaertsCAntimisiarisSGMultifunctional nanoliposomes with curcumin-lipid derivative and brain targeting functionality with potential applications for Alzheimer diseaseEur J Med Chem20148017518324780594
   PubMed Web of Science ®Google Scholar
• PodolskiIYPodlubnayaZAKosenkoEAEffects of hydrated forms of C-60 fullerene on amyloid beta-peptide fibrillization in vitro and performance of the cognitive taskJ Nanosci Nanotechnol200774–51479148517450915
   PubMed Web of Science ®Google Scholar
• IsmailMFElMeshadANSalemNAHPotential therapeutic effect of nanobased formulation of rivastigmine on rat model of Alzheimer’s diseaseInt J Nanomedicine2013839340623378761
   PubMed Web of Science ®Google Scholar
• YangZZhangYGYangYLAPharmacological and toxicological target organelles and safe use of single-walled carbon nanotubes as drug carriers in treating Alzheimer diseaseNanomedicine20106342744120056170
   PubMed Web of Science ®Google Scholar